[1]
M. Sobczyk, D. Żuraw, P. Oleksa, K. Jasiński, M. Porzak, and M. Dacka, “SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases”, Prosp. Pharm. Sc., vol. 22, no. 1, pp. 16–22, Feb. 2024.